A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker
出版年份 2022 全文链接
标题
A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker
作者
关键词
-
出版物
Cancers
Volume 14, Issue 7, Pages 1651
出版商
MDPI AG
发表日期
2022-03-25
DOI
10.3390/cancers14071651
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning
- (2021) Jing Ke et al. LABORATORY INVESTIGATION
- Data-efficient and weakly supervised computational pathology on whole-slide images
- (2021) Ming Y. Lu et al. Nature Biomedical Engineering
- Multi-Modal Evolutionary Deep Learning Model for Ovarian Cancer Diagnosis
- (2021) Rania M. Ghoniem et al. Symmetry-Basel
- Weakly Supervised Deep Learning Approach to Breast MRI Assessment
- (2021) Michael Z Liu et al. ACADEMIC RADIOLOGY
- Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning
- (2021) Ching-Wei Wang et al. Scientific Reports
- Deep Learning Fast Screening Approach on Cytological Whole Slides for Thyroid Cancer Diagnosis
- (2021) Yi-Jia Lin et al. Cancers
- Weakly-supervised deep learning for ultrasound diagnosis of breast cancer
- (2021) Jaeil Kim et al. Scientific Reports
- AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients
- (2021) Po-Chao Hsu et al. Journal of Clinical Medicine
- The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis
- (2020) Kuo-Min Su et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
- (2020) Josep Garcia et al. CANCER TREATMENT REVIEWS
- Treatment of Recurrent Epithelial Ovarian Cancer
- (2020) Carlota Claussen et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images—The ACDC@LungHP Challenge 2019
- (2020) Zhang Li et al. IEEE Journal of Biomedical and Health Informatics
- Applications of machine learning in drug discovery and development
- (2019) Jessica Vamathevan et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
- (2019) Gabriele Campanella et al. NATURE MEDICINE
- Inflammasome as a promising therapeutic target for cancer
- (2019) Chaelin Lee et al. LIFE SCIENCES
- Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
- (2019) Kaustav Bera et al. Nature Reviews Clinical Oncology
- Cascade R-CNN: High Quality Object Detection and Instance Segmentation
- (2019) Zhaowei Cai et al. IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
- Automatic classification of ovarian cancer types from cytological images using deep convolutional neural networks
- (2018) Miao Wu et al. BIOSCIENCE REPORTS
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Survival outcome prediction in cervical cancer: Cox models versus deep-learning model
- (2018) Koji Matsuo et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer
- (2018) Shuo Wang et al. RADIOTHERAPY AND ONCOLOGY
- Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks
- (2017) Shaoqing Ren et al. IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
- Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma
- (2017) Chia-Ming Chang et al. Oncotarget
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma
- (2016) Marta Szajnik et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity
- (2015) Si Ming Man et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Deep learning
- (2015) Yann LeCun et al. NATURE
- The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer
- (2014) A. Backen et al. CLINICAL CANCER RESEARCH
- Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab
- (2014) Karina Dahl Steffensen et al. EUROPEAN JOURNAL OF CANCER
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Markers of Response for the Antiangiogenic Agent Bevacizumab
- (2013) Diether Lambrechts et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammation and oxidative stress in angiogenesis and vascular disease
- (2013) Young-Woong Kim et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- AIM2, an IFN-Inducible Cytosolic DNA Sensor, in the Development of Benign Prostate Hyperplasia and Prostate Cancer
- (2013) Larissa Ponomareva et al. MOLECULAR CANCER RESEARCH
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
- (2012) Bradley J. Monk et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
- (2011) A. H. Beck et al. Science Translational Medicine
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
- (2009) George Pentheroudakis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started